This message was sent to ##Email##
|
|
|
|
|
| |
Popular Science
As we all learned in health class, when a baby animal is created, genetic material from two biological parents combines to create a new being—one with some genes from each parent. What you may not know is that a third genetic element is involved in this process, a hitchhiker whose existence and self-propagation may be essential to life as we know it.
READ MORE
Medical News Today
Using genomic data from more than 1 million people, scientists have picked out 151 genes that are likely associated with atrial fibrillation, which is a condition that causes irregular heartbeat and raises the risk of stroke.
READ MORE
PLOS via ScienceDaily
A father's genes are no longer thought to just provide a blueprint for the growth and development of their offspring. Research finds that paternal genes can affect the type of care the offspring receives both before and after they are born.
READ MORE
Lund University via ScienceDaily
A unique study has discovered that there is a genetic sexual conflict in the immune system in animals. In females, the variation in central genes of the immune system is too high, whereas in males, it is too low. The researchers argue that the conflict is linked to differences in the immune responses of females and males.
READ MORE
ABC News
Lung cancer death rates for women worldwide are expected to increase over the next 12 years and the problem will be worse in high-income countries than middle-income ones, according to a new study published in the Journal of Cancer Research.
READ MORE
U.S. News & World Report
A long-anticipated study into the cancer risks of New Mexico residents living near the site of the world's first atomic bomb test likely will be published in 2019, the National Cancer Institute announced.
Institute spokesman Michael Levin told The Associated Press that researchers are examining data on diet and radiation exposure on residents who lived near the World War II-era Trinity Test site, and scientists expect to finish the study by early next year.
READ MORE
Medical News Today
A molecular discovery could explain why some cases of breast cancer do not respond to radiation therapy. It could also lead to additional treatments that improve the response in those cases.
The results of the new study, which the Medical University of South Carolina in Charleston led, now appear in the journal Nature Communications.
READ MORE
| | EMERGING MEDICAL TECHNOLOGIES |
USA Tpdau
Fifteen years ago, Humber River Hospital began its journey to become the first fully digital hospital in North America. Their commitment was to create a state-of-the-art acute care facility that put caring for patients, families, community, employees, physicians and volunteers first. The organizational leadership wanted to see HRH excel in professional patient care by utilizing the most innovative digital technologies available to improve accuracy, efficiency and safety.
READ MORE
Healthcare IT News
If ever a technology was the opposite of plug-and-play, artificial intelligence is it. Beyond the obvious table stakes – having sound information and a smart data strategy – getting AI right requires a broad array of closely interrelated technologies to work well together. And it demands that each organization be able to tailor its deployments to their own particular needs.
READ MORE
Forbes
The Wall Street Journal recently noted that the United States “will soon spend close to 20 percent of its GDP” on healthcare. While it might not be possible to address the rising costs of healthcare in the immediate future, there are steps that can be taken to address issues of customer service and efficiency to improve the overall healthcare experience, while ensuring the protection of customer privacy.
READ MORE
| | BIOTECH/DIAGNOSTICS/PERSONALIZED MEDICINE |
Health Data Management
As part of the pre-appointment activities before an annual physical, patients at NorthShore University HealthSystem complete an electronic risk-assessment questionnaire to determine if genomic testing for certain inherited cancers, cardiovascular diseases or other medical conditions is appropriate for them.
READ MORE
Forbes
Proponents of precision medicine cite the growing numbers of successful precision cancer drugs. The examples of Herceptin (trastuzumab), Gleevec (imatinib mesylate), Xalkori (crizotinib), and Zelboraf (vemurafenib) come to mind. Skeptics, on the other hand, focus on the fact that only 9% of genetic mutations are actionable.
READ MORE
NPR
The first prescription medication extracted from the marijuana plant is poised to land on pharmacists' shelves this fall. Epidiolex, made from purified cannabidiol, or CBD, a compound found in the cannabis plant, is approved for two rare types of epilepsy.
Its journey to market was driven forward by one family's quest to find a treatment for their son's epilepsy.
READ MORE
Stowers Institute for Medical Research via ScienceDaily
Researchers from the Stowers Institute for Medical Research and collaborators have identified a way to expand blood-forming, adult stem cells from human umbilical cord blood (hUCB). This development could make these cells available to more people, and be more readily accepted in those who undergo adult stem cell treatments for conditions such as leukemia, blood disorders, immune system diseases, and other types of cancers, but who do not have an appropriate available bone marrow match.
READ MORE
University of California - San Diego via ScienceDaily
Researchers report that they have successfully created spinal cord neural stem cells (NSCs) from human pluripotent stem cells (hPSCs) that differentiate into a diverse population of cells capable of dispersing throughout the spinal cord and can be maintained for long periods of time.
READ MORE
Forbes
Everyone knows that the health system is broken. And everyone knows if it were easy to fix, someone would have done it by now. But the truth is, there are fragmented processes throughout the system - particularly as they relate to referring patients, and their health information, to others in the ecosystem.
READ MORE
Health Payer Intelligence
CMS has announced that monthly Medicare Part D premiums are expected to fall from $33.59 in 2018 to $32.50 in 2019 as new policies to reduce Medicare’s drug costs take effect.
Earlier in 2018, CMS issued a final rule that made several changes to Medicare Part D drug purchasing such as increasing generic drug substitution across Medicare, lowering the cost of biosimilars for consumers, and expanding the number of available Part D plans and pharmacy options.
READ MORE
| | FDA: NEW TREATMENTS AND TECHNOLOGY |
Washington Examiner
The Food and Drug Administration wants to get more companies to make drugs that can help treat opioid addiction.
The agency sent out new recommendations on Monday for medication-assisted treatment drugs with the goal of approving more of them. The recommendations come as Congress is hoping to expand access to such drugs as a way to combat the opioid epidemic.
READ MORE
| | ACCOUNTABLE CARE ORGANIZATIONS |
Healthcare Dive
MSSP has shown promise, and ACOs are joining up, though most are not eager to take on risk. In a recent National Association of ACOs (NAACOs) survey, 71 percent of ACOs said they will exit the program next year if forced to assume risk. About 6 percent said they weren't sure what they would do, while 23 percent said they would likely stick with the program.
READ MORE
Health Data Management
Better use of patient data enabled Palmetto Primary Care Physicians to improve care transitions, education and quality.
The South Carolina-based organization worked with Optum Analytics to mine patient care data and track physician performance through provider scorecards.
The multi-site practice, with 36 clinics and 124 providers, created a competition to see which could most effectively use data-based insights.
READ MORE
|
|
The University of Rochester School of Nursing offers the first 100% online Care Management Education program from a top-tier academic medical center. Whether it’s onboarding new care managers or renewing a managed care nursing certification, the UR School of Nursing’s courses are all taught by practicing experts. Students learn cutting-edge strategies to improve patient experience, manage population health, and reduce health care costs. The ABMCN has endorsed all 68 contact hours as preapproved renewal credits. Please click here for more information.
|
| Senseonics today announced the U.S. Food and Drug Administration has approved its Pre-market Approval (PMA) application to market the company’s Eversense® Continuous Glucose Monitoring (CGM) System to people with diabetes in the United States. The system is the first and only CGM system to feature an implantable glucose sensor and provide long-term continuous monitoring for up to three months. Please click here to view the full press release..
|
|
Novo Nordisk and the National Association of Managed Care Physicians (NAMCP) Medical Directors Institute have released the supplement titled “Management of Obesity: Considerations in Managed Care Medicine” in the Journal of Managed Care Medicine. Obesity is a chronic, relapsing, multifactorial, neurobehavioral disease resulting in adverse metabolic, biomechanical, and psychosocial consequences. The medical and financial burden of obesity significantly affects individuals, health care providers, employers, payers, and society. This supplement provides an extensive overview of the problem of obesity, the benefits of modest weight loss, and why various stakeholders are affected by and should address the issue. Click here to view the published article on the important topic of obesity management.
|
| Please take a quick minutes and let us know what you think of our eNews. The following survey will only take 2-3 minutes to complete.
Click here to take the survey.
|
|
Seattle Genetics announced an FDA approved label expansion for our lead product/program Adcetris (Brentuximab Vedotin) in combination with chemotherapy for adults with previously untreated stage III or IV classical Hodgkin Lymphoma. Click here for more information.
|
| Advanced Accelerator Applications, a Novartis Company, Receives US FDA Approval for LUTATHERA®, a First-in Class Treatment for Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs). Please click here to read the entire press release. |
|
The Alliance for Regenerative Medicine (ARM) and the National Association of Managed Care Physicians (NAMCP) Medical Directors Institute announced today the joint release of their recent study of medical director perspectives on value demonstration and reimbursement for regenerative and advanced therapies. Click here to view the published article about the study.
|
| The Centers for Medicare & Medicaid Services (CMS) has finalized a New Technology Ambulatory Payment Classification (APC) for the HeartFlow® FFRct Analysis, a first-of-its-kind non-invasive technology that helps clinicians diagnose and treat patients with suspected coronary artery disease. Under the APC payment system, hospitals enrolled in Medicare that bill CMS for the HeartFlow FFRct Analysis for Medicare patients are eligible for reimbursement effective January 1st, 2018. Please click here to view the full press release. |
|
Missed last week's issue? See which articles your colleagues read most.
|
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
